Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alopecia Areata(AA)”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Large-scale testing (Phase 3)Study completedNCT03732807
What this trial is testing

PF-06651600 for the Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 718
Not applicableStudy completedNCT07101471
What this trial is testing

Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation

Who this might be right for
Alopecia Totalis/UniversalisAlopecia Areata(AA)
NanoAlvand 296
Testing effectiveness (Phase 2)Active Not RecruitingNCT06018428
What this trial is testing

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Who this might be right for
Alopecia Areata
Q32 Bio Inc. 75
Testing effectiveness (Phase 2)Study completedNCT02018042
What this trial is testing

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

Who this might be right for
Alopecia Areata
Columbia University 15
Early research (Phase 1)Looking for participantsNCT06799520
What this trial is testing

Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableLooking for participantsNCT06531109
What this trial is testing

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Who this might be right for
Alopecia Areata
Pfizer 850
Testing effectiveness (Phase 2)Study completedNCT06060977
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

Who this might be right for
Alopecia Areata (AA)
Inmagene LLC 29
Not applicableNot Yet RecruitingNCT07226531
What this trial is testing

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

Who this might be right for
Alopecia Areata
Pfizer 300
Testing effectiveness (Phase 2)Ended earlyNCT02553330
What this trial is testing

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Who this might be right for
Alopecia Areata
Incyte Corporation 90
Not applicableLooking for participantsNCT06573593
What this trial is testing

Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study

Who this might be right for
Alopecia AreataJanus Kinase Inhibitors
Second Affiliated Hospital, School of Medicine, Zhejiang University 150
Large-scale testing (Phase 3)Looking for participantsNCT07023302
What this trial is testing

Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

Who this might be right for
Alopecia Areata
AbbVie 123
Testing effectiveness (Phase 2)Looking for participantsNCT05551793
What this trial is testing

Regeneron AA Multicenter (Dupilumab)

Who this might be right for
Alopecia Areata
Emma Guttman 68
Not applicableStudy completedNCT07455708
What this trial is testing

Impact of NR3C1 rs41423247 (BclI) Polymorphism on Disease Severity in Alopecia Areata

Who this might be right for
Alopecia Areata(AA)
Benha University 120
Testing effectiveness (Phase 2)Study completedNCT02197455
What this trial is testing

Tofacitnib for the Treatment of Alopecia Areata and Variants

Who this might be right for
Alopecia Areata (AA)Alopecia Totalis (AT)Alopecia Universalis (AU)
Yale University 30
Early research (Phase 1)Looking for participantsNCT06602232
What this trial is testing

DR-01 in Subjects With Alopecia Areata and Vitiligo

Who this might be right for
Alopecia AreataVitiligo
Dren Bio 80
Testing effectiveness (Phase 2)Study completedNCT06786689
What this trial is testing

To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia Areata(AA)
Sheikh Zayed Medical College 60
Not applicableLooking for participantsNCT06562270
What this trial is testing

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

Who this might be right for
Alopecia Areata
CorEvitas 1,500
Early research (Phase 1)Study completedNCT05650333
What this trial is testing

Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

Who this might be right for
Alopecia Areata
Pfizer 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204
What this trial is testing

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Who this might be right for
Alopecia AreataAlopecia Totalis (AT)Alopecia Universalis
Hayat Abad Medical Complex, Peshawar 78
Testing effectiveness (Phase 2)Ended earlyNCT03759340
What this trial is testing

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Who this might be right for
Alopecia AreataAlopecia UniversalisAlopecia Totalis
Aclaris Therapeutics, Inc. 56
Load More Results